Effect of long-term treatment with complete Freund's adjuvant on KK-Ay mouse, a model of non-insulin-dependent diabetes mellitus

Clinical Immunology and Immunopathology

Volumn 83, Issue 1, 1997, Pages 53-59

  Muto, Y ^a   Satoh, J ^a   Muto, G ^a   Masuda, T ^b   Sagara, M ^a   Fukuzawa, M ^a   Miyaguchi, S ^a   Qiang, X L ^a   Sakata, Y ^a   Nakazawa, T ^a   Ikehata, F ^a   Toyota, T ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CREATININE; FREUND ADJUVANT; INSULIN; PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; HISTOLOGY; HYPERTRIGLYCERIDEMIA; IMMUNOTHERAPY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL;

EID: 0031127032     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4328     Document Type: Article

References (24)

1. 1. Dinneen, S., Gerich, J., and Rizza, R., Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 327, 707-713, 1992.
2. 2. Hofmann, C. A., and Colca, J. R., New oral thiazolidinedione antidiabetic agents act as insulin sensitizers. Diabetes Care 15, 1075-1078, 1992.
3. 3. Than, S., Ishida, H., Inaba, M., Fukuda, Y., Seino, Y., Adachi, M., Imura, H., and Ikehara, S., Bone marrow transplantation as a strategy for treatment of non-insulin-dependent diabetes mellitus in KK-Ay mice. J. Exp. Med. 176, 1233-1238, 1992.
4. 4. Zhu, X. P., Satoh, J., Muto, G., Muto, Y., Sagara, M., Takahashi, K., Seino, H., Hirai, S., Masuda, T., Tanaka, S., Ishida, H., Seino, Y., and Toyota, T., Improvement of glucose tolerance with immunomodulators in type 2 diabetic animals. Biotherapy, in press.
5. 5. Kondo, K., Nozawa, K., Tomida, T., and Ezaki, K., Inbred strains resulting from Japanese mice. Bull. Exp. Anim. 6, 107-112, 1957.
6. 6. Iwatsuka, H., Shino, A., and Suzuoki, Z., General survey of diabetic features of yellow KK mice. Endocrinol. Jpn. 17, 23-35, 1970.
7. 7. Diani, A. R., Sawada, G. A., Hannah, B. A., Jodelis, K. S., Connell, M. A., Connell, C. L., Vidmar, T. J., and Wyse, B. M., Analysis of pancreatic islet cells and hormone content in the spontaneously diabetic KK-Ay mouse by morphometry, immunocytochemistry and radioimmunoassay. Virchow's Arch. A 412, 53-61, 1987.
8. 8. Goto, Y., and Kakizaki, M., The spontaneous-diabetes rat: A model of non-insulin dependent diabetes mellitus. Proc. J. Acad. 57, 381-384, 1981.
9. 9. Ikeda, H., Shino, A., Matsuo, T., Iwatsuka, H., Suzuoka, Z. A., New genetically obese-hyperglycemic rat (Wistar fatty). Diabetes 30, 1045-1050, 1981.
10. 10. Clark, C. M., and Lee, D. A., Prevention and treatment of the complications of diabetes mellitus. N. Engl. J. Med. 332, 1210-1217, 1995.
11. 11. Suwa, N., and Takahashi, T., Morphological and morphometrical analysis of circulation in hypertension and ischemic kidney. In "Fortschritte der morphologischen Pathologie" (F. Buchner, Ed.), pp. 1-130, Urban & Schwarzenberg, Munich/Berlin/Vienna, 1971.
12. 12. Diani, A. R., Sawada, G. A., Zhang, N. Y., Wyse, B. M., Connell, C. L., Vidmar, T. J., and Connell, M. A., The KK-Ay mouse: A model for the rapid development of glomerular capillary basement membrane thickening. Blood Vessels 24, 297-303, 1987.
13. 13. Velasquez, M. T., Kimmel, P. L., and Michaelis, O. E., Animal models of spontaneous diabetic kidney disease. FASEB J. 4, 2850-2859, 1990.
14. 14. Shintani, S., Satoh, J., Seino, H., Goto, Y., and Toyota, T., Mechanism of action of a streptococcal preparation (OK-432) in prevention of autoimmune diabetes in NOD mice: Suppression of generation of effector cells for pancreatic B cell destruction. J. Immunol. 144, 136-141, 1990.
15. 15. Harada, M., Kishimoto, Y., and Makino, S., Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes Res. Clin. Pract. 8, 85-89, 1990.
16. 16. Sadelain, M. W. J., Qin, H. Y., Lauzon, J., and Singh, B., Prevention of type 1 diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39, 583-589, 1990.
17. 17. McCance, D. R., Hanson, R. L., Charles, M. A., Jacobsson, L. T. H., Pettitt, D. J., Bennett, P. H., and Knowler, W. C., Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. Br. Med. J. 308, 1323-1328, 1994.
18. 18. del Rey, A., and Besedovsky, H., Antidiabetic effects of interleukin 1. Proc. Natl. Acad. Sci. USA 86, 5943-5947, 1989.
19. 19. Hotamisligil, G. S., Shargill, N. S., and Spiegelman, B. M., Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance. Science 259, 87-91, 1993.
20. 20. Sakurai, Y., Zhang, X. J., and Wolfe, R. R., TNF directly stimulates glucose uptake and leucine oxidation and inhibits FFA flux in conscious dogs. Am. J. Physiol. 270, E864-E872, 1996.
21. 21. Grunfeld, C., Zhao, C., Fuller, J., Pollock, A., Moser, A., Friedman, J., and Feingold, K. R., Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters: A role for leptin in the anorexia of infection. J. Clin. Invest. 97, 2152-2157, 1996.
22. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 83, 803-812, 1995.
23. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83, 813-819, 1995.
24. 24. Lowell, B. B., S-Susulic, V., Hamann, A., Lawitts, J. A., Himms-Hagen, J., Boyer, B. B., Kozak, L. P., and Flier, J. S., Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366, 740-742, 1993.